IL6 and posterior cortical atrophy: The result indicated that IL-6 (OR = 1.073, 95% CI: 1.081-3.843) is a risk factor that differentiates PCa from benign prostate diseases, and F/T (OR = 0.092, 95% CI: 0.023-0.106) may be a protective factor (Table 2).